Clinical Trials Directory

Trials / Completed

CompletedNCT03736733

Relevance of an Adapted and Supervised Physical Activity Program in Fibromyalgia Patients. The FIMOUV 1 Study.

Relevance of an Adapted and Supervised Physical Activity Program in Fibromyalgia Patients. The FIMOUV 1 Study. Interventional, Controlled, Randomized, Open Study of an Original Outpatient Management.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Fibromyalgia affects 2 to 5% of adults in the general population. Patients describe a combination of symptoms centred around fatigue not induced by exercise and not relieved by rest. The diagnosis of fibromyalgia is self-perpetuating by the deconditioning, consequence of a reduced muscle mass due to inactivity and periods of prolonged rest. Thus, it seems fundamental to develop other non-drug approaches: among them, adapted physical activity is recommended by most learned societies because of a good level of evidence (Level 1, Grade A). The question remains, however, whether simple advice to resume physical activity is sufficient (routine care with medical assessment at 3 months) or whether a physical activity supervised inside and outside the hospital is not more relevant.

Conditions

Interventions

TypeNameDescription
OTHERphysical activity programTwo weekly exercise sessions at the university hospital of St-Etienne for 1 month then relay outside in a sports association or club certified "Sports Health" in the Loire (42) or Haute-Loire (43) for 2 months.
OTHERAdvice and recommendations of physical activity at homeAdvice and recommendations of physical activity at home (= current clinical practice, from 1 to 3 sessions per week in autonomy).

Timeline

Start date
2018-11-15
Primary completion
2019-12-19
Completion
2021-06-11
First posted
2018-11-09
Last updated
2022-09-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03736733. Inclusion in this directory is not an endorsement.